"The biggest innovations in the world will come from the intersection of biology & technology." - Steve Jobs
What's powering this intersection of the digital and health world's innovations? A generational shift toward mobile connectivity, technology advancements that allow for big data processing and analytics, and changes to healthcare models, are all part of this massive shift. But how do we get from digital health that focuses on patient engagement through apps and wearables to digital medicine that focuses on the diagnosis and treatment of patients?
Join thought leaders from IBM, iGan Partners (Rowanwood Ventures), LEAGUE, MaRS Innovation and Johnson & Johnson Innovation at JLABS @ Toronto for a panel discussion around the merging of technology and medicine and how we can start making the shift towards the commercialization of these products to begin improving the lives of patients.
Also hear from Johnson & Johnson Innovation's Digital Health Innovation Lead on how they are helping & partnering with startups and making a commitment to digital health innovation globally.
Afterwards, hear pitches from companies within the digital health space, while networking with your peers in the industry at a cocktail reception.
Lori Casselman | Chief Health Officer, League read bio»
Cris De Luca | Digital Health Innovation Leader, Johnson & Johnson Innovation read bio»
Kuljeev Singh | Principal, iGan Partners (Rowanwood Ventures) read bio»
Daniel Sinai | Senior Executive, Innovation, IBM Canada read bio»
[Moderator] Fanny Sie | Manager, Technology & Venture Development, MaRS Innovation read bio»
Digital Health Companies Pitching:
- A4i Read More»
- HAPPYneuron Read More»
- ITI Communication Read More»
- Maela Read More»
- Neutun Labs Read More»
- NG Biotech Read More»
5:00 PM | Registration Opens & Networking
5:20 PM | Presentation, Digital Health at JLABS
5:30 PM | Digital Health Company Pitches
6:15 PM | Panel Discussion
7:15 PM | Networking
8:00 PM | Program Close
JLABS @ Toronto
661 University Ave, Suite 1300
Lori Casselman | Chief Health Officer, League
Lori Casselman is Chief Health Officer at League Inc. LEAGUE is a new digital health benefits & wellness platform that is transforming the corporate benefits landscape by empowering employees to live their best lives. Lori has 20 years of experience in the healthcare and insurance industries, and joined League most recently from Sun Life Financial, where she held several executive roles in the Group Benefits organization.
Lori holds accountability for League’s health focus, including the management of a unique health provider network & e-commerce marketplace, as well as an innovative suite of corporate and consumer health initiatives. Lori has been a long-standing industry advocate for a multi-disciplinary, prevention-based approach to organizational and employee health - from prevention to disability management.
Prior to Sun Life, Lori was an executive with Buffett & Company, one of Canada’s first digital health & wellness businesses.
Lori has a BA in Kinesiology, a BSc in Nutrition, an MSc in Exercise Physiology, and has completed the Ivey Executive Leadership program. She has held positions on the advisory boards of the Health, Work & Wellness Conference, the Sanofi-Aventis Healthcare Survey, and Get Active Toronto.
Connect with Lori:
Cris De Luca, MS | Digital Health Innovation Leader, Johnson & Johnson Innovation
Cris is the Digital Health Innovation Leader at Johnson & Johnson Innovation, Boston where he is responsible for external healthcare technology innovation strategy and new ventures. Cris was previously Associate Director at Novartis Institutes for BioMedical Research where he led a Research Informatics organization building social computing and emerging technology programs.
In 2010, Cris Co-Founded the largest startup venture pitch competition in the U.S. called Ultra Light Startups, accelerating hundreds of bootstrapping entrepreneurs in New England, New York, and Silicon Valley. Cris was recognized by the Boston Business Journal as a 40 Under 40 game changer and an honoree of MedTech Boston's 40 Under 40 Healthcare Innovators line-up. He holds a Bachelor of Science in Business Administration from Suffolk University and a Master of Science in Computer Information Systems from Boston University.
Connect with Cris:
Kuljeev Singh | Principal, iGan Partners (Rowanwood Ventures)
Kuljeev has several years of venture capital experience investing in early stage tech and healthcare. He is currently a Principal in the investment team at iGan Partners, a venture capital firm focused on early stage technology and digital health companies. As Principal, he is involved in the origination, diligence, structuring, and monitoring of the iGan portfolio, including board positions across the portfolio. Prior to iGan Partners, Kuljeev was at High Park Capital, a Toronto based private equity firm focused on buyout opportunities in technology and healthcare.
Kuljeev has been on the other side of the table as a co-founder of two startups, he is an active angel investor and mentor to various early stage SaaS, internet and digital health companies. Kuljeev graduated with a Bachelor of Mathematics (Honors) from the University of Waterloo.
Connect with Kuljeev:
Daniel Sinai | Senior Executive, Innovation, IBM Canada
Dan is currently a Senior Executive at IBM Canada where he works with the Canadian start-up community and implements the company’s innovation and incubation initiatives.
Prior to joining IBM, Dan served as Western University's Associate Vice-President (Research). In this capacity, Dan set the strategic direction for, and led, a team of research administration professionals at one of Canada’s leading research-intensive universities.
A graduate of the University of Waterloo, Dan has held various key research administration positions with both the Government of Ontario and the Government of Canada. He also has extensive R&D program and policy experience, and has worked for several high technology companies, including Nortel and EK3 Technologies.
Dan and his family have lived in London, Ontario, Canada for more that 15 years, where he has served on various local Boards of Directors.
Connect with Daniel:
Fanny Sie | Manager, Technology & Venture Development, MaRS Innovation
Fanny Sie's academic studies include Human Biology (HonsBSc) and a Radiation Therapy degree (BSc/M.R.T.(T.)) at the University of Toronto (U of T).
She worked at Princess Margaret Hospital as a radiation research therapist for eight years. In this dual role, she was involved in managing treatment delivery for cancer patients and in researching and developing initiatives for novel optical and imaging devices utilized for treatment target optimization. While enrolled in U of T's Masters of Management of Innovation program, Fanny studied and aided in market-entry strategies of new technologies at various stages of the commercialization pipeline. This education prepared her for the role of clinical applications business analyst for Elekta Oncology Systems in 2009, where she was a liaison between internal developmental engineers, product management, business units and a clinician-based clientele. Her responsibilities included ground-up development, configuration, training and implementing progressive technologies for cancer centers worldwide.
Fanny's current focus is on creating and deploying strategies to accelerate the development and scale of digital health solutions to the market by collaborating with academic institutions, industry partners, investors and government.
Connect with Fanny:
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.